Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion type Assertion NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_head.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion description "[Considering only those patients with cerebral toxoplasmosis from whom CSF was collected before or during the first week of antitoxoplasmic therapy, sensitivity rose to 50%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_provenance.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion evidence source_evidence_literature NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_provenance.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion SIO_000772 8958252 NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_provenance.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion wasDerivedFrom befree-20140225 NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_provenance.
- NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_assertion wasGeneratedBy ECO_0000203 NP934139.RAHOkk57ewEW_DzZhN_2RL6P-PhprmqMh6FLfFh3sDYAk130_provenance.